It was reported that puerarin prevented cardiac hypertrophy through regulating the AMPK, mTOR and Nrf2 pathway, suggesting that puerarin may be potential drug candidate for myocardial hypertrophy (Cai et al., 2018; Liu et al., 2015). This evidence concerns the gene MTOR and cardiac hypertrophy.